{"count": 4, "results": [{"_id": "37126871", "pmid": 37126871, "title": "A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder.", "journal": "Eur Neuropsychopharmacol", "authors": ["Weiser M", "Levi L", "Park J", "Nastas I", "Matei V", "Davidson M", "Arad I", "Dudkiewicz I", "Davis JM"], "date": "2023-04-29T00:00:00Z", "doi": "10.1016/j.euroneuro.2023.04.007", "meta_date_publication": "2023 Apr 29", "meta_volume": "73", "meta_issue": "", "meta_pages": "65-74", "score": 50260.28, "text_hl": "A randomized controlled trial of add-on @CHEMICAL_Naproxen @CHEMICAL_MESH:D009288 @@@naproxen@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and their combination for the treatment of @DISEASE_Schizophrenia @DISEASE_MESH:D012559 @@@schizophrenia@@@ or @<m>DISEASE_Psychotic_Disorders</m> @DISEASE_MESH:D011618 @@@schizoaffective disorder@@@.", "citations": {"NLM": "Weiser M, Levi L, Park J, Nastas I, Matei V, Davidson M, Arad I, Dudkiewicz I, Davis JM. A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder. Eur Neuropsychopharmacol. 2023 Apr 29;73():65-74. PMID: 37126871", "BibTeX": "@article{37126871, title={A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder.}, author={Weiser M and Levi L and Park J and Nastas I and Matei V and Davidson M and Arad I and Dudkiewicz I and Davis JM}, journal={Eur Neuropsychopharmacol}, volume={73}, pages={65-74}}"}}, {"_id": "26674520", "pmid": 26674520, "pmcid": "PMC4661708", "title": "Simvastatin augmentation for recent-onset psychotic disorder: A study protocol", "journal": "BBA Clin", "authors": ["Begemann MJ", "Schutte MJ", "Slot MI", "Doorduin J", "Bakker PR", "van Haren NE", "Sommer IE"], "date": "2015-07-03T00:00:00Z", "doi": "10.1016/j.bbacli.2015.06.007", "meta_date_publication": "2015 Dec", "meta_volume": "4", "meta_issue": "", "meta_pages": "52-58", "score": 50074.016, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ augmentation for recent-onset @<m>DISEASE_Psychotic_Disorders</m> @DISEASE_MESH:D011618 @@@psychotic disorder@@@: A study protocol", "citations": {"NLM": "Begemann MJ, Schutte MJ, Slot MI, Doorduin J, Bakker PR, van Haren NE, Sommer IE. Simvastatin augmentation for recent-onset psychotic disorder: A study protocol BBA Clin. 2015 Dec;4():52-58. PMID: 26674520", "BibTeX": "@article{26674520, title={Simvastatin augmentation for recent-onset psychotic disorder: A study protocol}, author={Begemann MJ and Schutte MJ and Slot MI and Doorduin J and Bakker PR and van Haren NE and Sommer IE}, journal={BBA Clin}, volume={4}, pages={52-58}}"}}, {"_id": "8345888", "pmid": 8345888, "title": "[Psychiatric disorders with use of simvastatin].", "journal": "Ned Tijdschr Geneeskd", "authors": ["Duits N", "Bos FM"], "date": "1993-06-26T00:00:00Z", "meta_date_publication": "1993 Jun 26", "meta_volume": "137", "meta_issue": "26", "meta_pages": "1312-5", "score": 50065.246, "text_hl": "Three @SPECIES_9606 @@@patients@@@ are described with serious @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@psychiatric complications@@@ related to use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. The @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@psychiatric symptoms@@@ concerned were mainly @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@, @DISEASE_Anxiety @DISEASE_MESH:D001007 @@@anxiety@@@ and suicidal tendencies but also @<m>DISEASE_Psychotic_Disorders</m> @DISEASE_MESH:D011618 @@@psychotic symptoms@@@. ", "citations": {"NLM": "Duits N, Bos FM. [Psychiatric disorders with use of simvastatin]. Ned Tijdschr Geneeskd. 1993 Jun 26;137(26):1312-5. PMID: 8345888", "BibTeX": "@article{8345888, title={[Psychiatric disorders with use of simvastatin].}, author={Duits N and Bos FM}, journal={Ned Tijdschr Geneeskd}, volume={137}, number={26}, pages={1312-5}}"}}, {"_id": "23782463", "pmid": 23782463, "pmcid": "PMC3680972", "title": "Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial", "journal": "Trials", "authors": ["Chaudhry IB", "Husain N", "Husain MO", "Hallak J", "Drake R", "Kazmi A", "Rahman Ru", "Hamirani MM", "Kiran T", "Mehmood N", "Stirling J", "Dunn G", "Deakin B"], "date": "2013-04-17T00:00:00Z", "doi": "10.1186/1745-6215-14-101", "meta_date_publication": "2013 Apr 17", "meta_volume": "14", "meta_issue": "", "meta_pages": "101", "score": 50054.18, "text_hl": "This is a two center, six-month, double-blind placebo controlled, factorial design study of @CHEMICAL_Ondansetron @CHEMICAL_MESH:D017294 @@@ondansetron@@@ and/or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ added to treatment as usual for @SPECIES_9606 @@@patients@@@ suffering from @DISEASE_Schizophrenia @DISEASE_MESH:D012559 @@@schizophrenia@@@, @<m>DISEASE_Psychotic_Disorders</m> @DISEASE_MESH:D011618 @@@schizoaffective disorder@@@, @<m>DISEASE_Psychotic_Disorders</m> @DISEASE_MESH:D011618 @@@psychosis@@@ not otherwise specified or @<m>DISEASE_Psychotic_Disorders</m> @DISEASE_MESH:D011618 @@@schizophreniform disorder@@@. ", "citations": {"NLM": "Chaudhry IB, Husain N, Husain MO, Hallak J, Drake R, Kazmi A, Rahman Ru, Hamirani MM, Kiran T, Mehmood N, Stirling J, Dunn G, Deakin B. Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial Trials. 2013 Apr 17;14():101. PMID: 23782463", "BibTeX": "@article{23782463, title={Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial}, author={Chaudhry IB and Husain N and Husain MO and Hallak J and Drake R and Kazmi A and Rahman Ru and Hamirani MM and Kiran T and Mehmood N and Stirling J and Dunn G and Deakin B}, journal={Trials}, volume={14}, pages={101}}"}}]}